While Bayer AG is considering how to respond to Monsanto Co.’s rejection of its $62 billion takeover bid, investors and analysts are questioning whether the German pharmaceutical and chemicals giant can up its offer.
from WSJ.com: US Business http://ift.tt/1WjecmC
via IFTTT
No comments:
Post a Comment